1. Home
  2. INSE vs RLYB Comparison

INSE vs RLYB Comparison

Compare INSE & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

N/A

Current Price

$4.40

Market Cap

83.6M

Sector

Technology

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

N/A

Current Price

$15.76

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INSE
RLYB
Founded
2002
2018
Country
United States
United States
Employees
N/A
6
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.6M
88.0M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
INSE
RLYB
Price
$4.40
$15.76
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $6.85
N/A
AVG Volume (30 Days)
★ 552.5K
24.9K
Earning Date
11-05-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 5.64
Revenue
★ $199,800,000.00
$858,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.15
N/A
P/E Ratio
★ N/A
$2.76
Revenue Growth
30.25
★ 43.00
52 Week Low
$3.10
$0.56
52 Week High
$9.95
$32.54

Technical Indicators

Market Signals
Indicator
INSE
RLYB
Relative Strength Index (RSI) 61.10 42.74
Support Level $3.31 $7.93
Resistance Level $8.42 $16.89
Average True Range (ATR) 0.31 1.79
MACD 0.15 0.01
Stochastic Oscillator 80.38 2.78

Price Performance

Historical Comparison
INSE
RLYB

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.

Share on Social Networks: